Concepts (101)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Staphylococcal Infections | 3 | 2020 | 266 | 1.240 |
Why?
|
| Propofol | 2 | 2017 | 91 | 1.090 |
Why?
|
| Disease Susceptibility | 2 | 2017 | 196 | 1.060 |
Why?
|
| Hypnotics and Sedatives | 2 | 2017 | 128 | 1.030 |
Why?
|
| T-Lymphocytes | 3 | 2020 | 1204 | 0.890 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 2 | 2020 | 78 | 0.730 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2023 | 432 | 0.730 |
Why?
|
| Natural Killer T-Cells | 4 | 2022 | 43 | 0.730 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2023 | 573 | 0.720 |
Why?
|
| Staphylococcus aureus | 1 | 2020 | 272 | 0.580 |
Why?
|
| Bacteremia | 1 | 2017 | 100 | 0.560 |
Why?
|
| Macrophages | 2 | 2017 | 568 | 0.530 |
Why?
|
| Kidney Diseases | 1 | 2017 | 316 | 0.490 |
Why?
|
| Bacterial Infections | 1 | 2015 | 183 | 0.470 |
Why?
|
| Mice | 9 | 2023 | 11538 | 0.290 |
Why?
|
| Antibodies, Viral | 3 | 2023 | 300 | 0.280 |
Why?
|
| Listeriosis | 2 | 2017 | 86 | 0.270 |
Why?
|
| Listeria monocytogenes | 2 | 2017 | 91 | 0.270 |
Why?
|
| Nucleocapsid | 1 | 2022 | 4 | 0.220 |
Why?
|
| Animals | 11 | 2023 | 26838 | 0.220 |
Why?
|
| Mitochondrial Proteins | 1 | 2023 | 125 | 0.210 |
Why?
|
| Interleukin-6 | 1 | 2023 | 259 | 0.200 |
Why?
|
| Bacterial Load | 2 | 2020 | 18 | 0.200 |
Why?
|
| Delirium | 1 | 2022 | 68 | 0.200 |
Why?
|
| Antigens, CD1 | 1 | 2020 | 36 | 0.180 |
Why?
|
| Immunity, Cellular | 1 | 2020 | 179 | 0.180 |
Why?
|
| Immunization | 1 | 2020 | 159 | 0.180 |
Why?
|
| Cognitive Dysfunction | 1 | 2022 | 137 | 0.180 |
Why?
|
| Energy Metabolism | 1 | 2021 | 275 | 0.170 |
Why?
|
| Lipids | 1 | 2020 | 267 | 0.160 |
Why?
|
| Hepatitis, Autoimmune | 1 | 2017 | 20 | 0.150 |
Why?
|
| Mitochondria | 1 | 2021 | 539 | 0.150 |
Why?
|
| Cells, Cultured | 3 | 2020 | 2839 | 0.150 |
Why?
|
| Disease Models, Animal | 3 | 2020 | 2270 | 0.140 |
Why?
|
| Antibodies, Monoclonal | 1 | 2022 | 1389 | 0.140 |
Why?
|
| Animals, Outbred Strains | 1 | 2015 | 17 | 0.130 |
Why?
|
| Antigens, CD1d | 3 | 2021 | 32 | 0.130 |
Why?
|
| Neutrophils | 1 | 2017 | 308 | 0.130 |
Why?
|
| Cell Count | 1 | 2015 | 197 | 0.130 |
Why?
|
| Kidney | 1 | 2020 | 1136 | 0.120 |
Why?
|
| Cross Infection | 1 | 2015 | 143 | 0.120 |
Why?
|
| Down-Regulation | 1 | 2015 | 512 | 0.120 |
Why?
|
| Dendritic Cells | 1 | 2017 | 430 | 0.120 |
Why?
|
| Mice, Inbred C57BL | 4 | 2022 | 3142 | 0.120 |
Why?
|
| Humans | 10 | 2023 | 86782 | 0.110 |
Why?
|
| Lymphocyte Activation | 3 | 2021 | 737 | 0.110 |
Why?
|
| Apoptosis | 1 | 2017 | 1699 | 0.090 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 2022 | 381 | 0.080 |
Why?
|
| Female | 5 | 2021 | 44741 | 0.080 |
Why?
|
| Disease Progression | 2 | 2023 | 1467 | 0.080 |
Why?
|
| Cell Differentiation | 2 | 2022 | 1491 | 0.060 |
Why?
|
| Quality of Life | 2 | 2023 | 1612 | 0.060 |
Why?
|
| Immunization, Secondary | 1 | 2023 | 31 | 0.060 |
Why?
|
| Cell Proliferation | 2 | 2020 | 1615 | 0.060 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2022 | 42 | 0.050 |
Why?
|
| Fatigue | 1 | 2023 | 175 | 0.050 |
Why?
|
| Immunity | 1 | 2023 | 137 | 0.050 |
Why?
|
| Proteome | 1 | 2023 | 127 | 0.050 |
Why?
|
| Virus Shedding | 1 | 2022 | 27 | 0.050 |
Why?
|
| Antibodies, Neutralizing | 1 | 2023 | 117 | 0.050 |
Why?
|
| Epitope Mapping | 1 | 2021 | 17 | 0.050 |
Why?
|
| Cross Reactions | 1 | 2021 | 109 | 0.050 |
Why?
|
| Proteomics | 1 | 2023 | 221 | 0.050 |
Why?
|
| Iron-Sulfur Proteins | 1 | 2021 | 12 | 0.050 |
Why?
|
| Electron Transport Complex III | 1 | 2021 | 13 | 0.050 |
Why?
|
| Methyltransferases | 1 | 2022 | 187 | 0.050 |
Why?
|
| RNA, Viral | 1 | 2022 | 331 | 0.050 |
Why?
|
| Antibodies | 1 | 2023 | 354 | 0.050 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2020 | 48 | 0.050 |
Why?
|
| Interleukin-15 | 1 | 2021 | 73 | 0.050 |
Why?
|
| Adoptive Transfer | 1 | 2020 | 169 | 0.050 |
Why?
|
| Gene Knockdown Techniques | 1 | 2021 | 241 | 0.050 |
Why?
|
| Interleukin-12 | 1 | 2020 | 109 | 0.050 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2020 | 162 | 0.050 |
Why?
|
| Vaccination | 1 | 2021 | 258 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 1 | 2021 | 1069 | 0.040 |
Why?
|
| Retrospective Studies | 2 | 2023 | 8609 | 0.040 |
Why?
|
| Interferon-gamma | 1 | 2020 | 445 | 0.040 |
Why?
|
| Host-Pathogen Interactions | 1 | 2020 | 232 | 0.040 |
Why?
|
| RNA | 1 | 2022 | 563 | 0.040 |
Why?
|
| Male | 4 | 2022 | 41095 | 0.040 |
Why?
|
| Lymphocyte Cooperation | 1 | 2017 | 5 | 0.040 |
Why?
|
| Incidence | 1 | 2022 | 1559 | 0.040 |
Why?
|
| Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 1 | 2017 | 34 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 2023 | 1993 | 0.040 |
Why?
|
| Mice, Knockout | 1 | 2021 | 1961 | 0.030 |
Why?
|
| Autoantibodies | 1 | 2017 | 268 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2020 | 1831 | 0.030 |
Why?
|
| Biomarkers | 1 | 2022 | 1730 | 0.030 |
Why?
|
| Lymphocytes | 1 | 2017 | 468 | 0.030 |
Why?
|
| Phenotype | 1 | 2020 | 2397 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2017 | 1563 | 0.030 |
Why?
|
| Immunity, Innate | 1 | 2017 | 419 | 0.030 |
Why?
|
| Cytokines | 1 | 2017 | 790 | 0.030 |
Why?
|
| B-Lymphocytes | 1 | 2017 | 728 | 0.030 |
Why?
|
| Cell Line | 1 | 2017 | 2480 | 0.030 |
Why?
|
| Inflammation | 1 | 2017 | 944 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2017 | 3313 | 0.020 |
Why?
|
| Aged | 1 | 2020 | 18427 | 0.010 |
Why?
|
| Middle Aged | 1 | 2020 | 25061 | 0.010 |
Why?
|
| Adult | 1 | 2020 | 25790 | 0.010 |
Why?
|